Leave Your Message
ADT1224-Etanercept Biosimilar-(TNF Receptor)-Research Biosimilar Antibody
Antibody

ADT1224-Etanercept Biosimilar-(TNF Receptor)-Research Biosimilar Antibody

  • Catalog Number ADT1224
  • Host CHO Cells
  • Species Human
  • Target TNF Receptor
  • Application ELISA, WB

Our expert team focuses on optimizing expression systems and refining purification strategies to ensure the high quality of our biosimilar antibodies.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

The tumor necrosis factor receptor superfamily (TNFRSF) is a protein superfamily of cytokine receptors characterized by the ability to bind tumor necrosis factors (TNFs) via an extracellular cysteine-rich domain

Product Specification

Catalog Number

ADT1224

Product Name

ADT1224-Etanercept Biosimilar-(TNF Receptor)-Research Biosimilar Antibody

Clonity

Monoclonal

Alternate Names

anti-mouse TNF Receptor antibody,  anti-TNF Receptor antibody,  anti TNF Receptor antibody,  recombinant TNF Receptor,  TNF Receptor antibody,  anti-TNF Receptor monoclonal antibody,  TNF Receptor antibodies,  TNF Receptor recombinant antibody,  TNF Receptor blocking antibody

Alias

etanercept-szzs,  etanercept-ykro,  Recombinant human TNF,  rhu TNFR:Fc,  rhu-TNFR:Fc,  TNFR-Immunoadhesin

Host

CHO Cells

Species

Human

Target

TNF Receptor

Size

1mg, 5mg

Research Area

Immunology

CAS Number

185243-69-0

Chemical Formula

C2224H3475N621O698S36

Product Description

Etanercept interfering with tumor necrosis factor (TNF),  a soluble inflammatory cytokine,  by acting as a TNF Inhibitionitor.

Mechanism of Action

There are two distinct receptors for TNF (TNFRs),  a 55 kilodalton protein (p55) and a 75 kilodalton protein (p75). The biological activity of TNF is dependent upon binding to either cell surface receptor (p75 or p55). Etanercept is a dimeric soluble form of the p75 TNF receptor that can bind to two TNF molecules,  thereby effectively removing them from circulation. Notably,  etancerpt is only capable of binding to the active trimeric form of TNF as its binding site is located in the cleft between subunits.TNF is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. Increased levels of TNF are found in tissues and fluids of those with rheumatoid arthritis,  psoriatic arthritis,  ankylosing spondylitis,  and plaque psoriasis.

Metabolism

As etanercept is a fusion protein antibody,  it is assumed to be metabolized via proteinases similarly to endogenous proteins.

Molecular Weight

51.23 KDa (Monomer)

Application

ELISA,  WB

Purity

>95% as determined by SDS-PAGE

Concentration

batch dependent

Buffer

Supplied in PBS,  PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

Reference

1. Balkwill,  F. (2006). “TNF-alpha in promotion and progression of cancer.” Cancer and Metastasis Reviews,  25(3),  409-416. DOI: 10.1007/s10555-006-9008-5.
2. Peters,  A. M.,  et al. (2015). “The role of TNF receptors in the regulation of immune responses.” Nature Reviews Immunology,  15(1),  1-10. DOI: 10.1038/nri.2014.139.
3. Ashkenazi,  A.,  & Dixit,  V. M. (1998). “Death receptors: Signaling and modulation.” Science,  281(5381),  1305-1308. DOI: 10.1126/science.281.5381.1305.